Arenaviral vaccine vectors to combat infectious diseases

Oncotarget

Volumn 7, Issue 29, 2016, Pages 44875-

  Dhanwani, Rekha ^a   Ly, Hinh ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arenavirus; LCMV; Pichinde virus; Reverse genetics; Vaccine vector

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS NUCLEOPROTEIN; VIRUS VECTOR; VIRUS VACCINE;

ANTIBODY PRODUCTION; ARENAVIRUS; DRUG SAFETY; EDITORIAL; HUMAN; IMMUNOGENICITY; INFLUENZA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PICHINDE VIRUS; VIRAL TROPISM; VIRUS GENOME; VIRUS RECOMBINANT; ANIMAL; ARENAVIRIDAE; GENETICS; IMMUNOLOGY; VIRUS INFECTION;

ANIMALS; ARENAVIRUS; HUMANS; VIRAL VACCINES; VIRUS DISEASES;

EID: 84979938849     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10405     Document Type: Editorial

References (5)

1. Choi Y and Chang J. Clin Exp Vaccine Res. 2013; 2: 97-105.
2. Meyer B and Ly H. J Virol. 2016; 90:3810-3818.
3. Emonet SF et al. PNAS.2009; 106: 3473-3478.
4. Dhanwani R et al. J Virol. 2015; 90:2551-2560.
5. Sommerstein R et al. PLoS Pathog. 2015; 11: e1005276.